相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
Suthinee Ithimakin et al.
CANCER RESEARCH (2013)
RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro
Sandra Casimiro et al.
PLOS ONE (2013)
Progesterone/RANKL Is a Major Regulatory Axis in the Human Breast
Tamara Tanos et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model
Jude Canon et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
RANK Induces Epithelial-Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
Marta Palafox et al.
CANCER RESEARCH (2012)
Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
William C. Dougall
CLINICAL CANCER RESEARCH (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+Breast Cancer by Expanding the Cancer Stem Cell Population
Hasan Korkaya et al.
MOLECULAR CELL (2012)
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab
David L. Lacey et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
RANKL inhibition: a promising novel strategy for breast cancer treatment
Eva Gonzalez-Suarez
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Receptor Activator of NF-κB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
Daniele Santini et al.
PLOS ONE (2011)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Control of mammary stem cell function by steroid hormone signalling
Marie-Liesse Asselin-Labat et al.
NATURE (2010)
Progesterone induces adult mammary stem cell expansion
Purna A. Joshi et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
Manfred Beleut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor, metastasis genes
Allison P. Armstrong et al.
PROSTATE (2008)
Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
Jude R. Canon et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis
Yu Zheng et al.
BONE (2007)
RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini
Eva Gonzalez-Suarez et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function
AP Armstrong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of the bone marrow microenvironment in multiple myeloma
GD Roodman
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
YX Cao et al.
CELL (2001)
A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro
T Yoneda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
JE Fata et al.
CELL (2000)
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
EF Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
